RXRX vs TOST · rev $14.1M vs P/E 161, rev $3.54B
Recursion Pharmaceuticals Inc (RXRX) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
RXRX currently screens at market cap $1.75B. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the RXRX and TOST stock pages for the full models.
Not investment advice.